Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017

Objective: The objective was to examine trends in the number of low-volume and nonmetropolitan mifepristone purchasers and their role in the expansion of medication abortion. Methods: We use deidentified data from Danco Laboratories, the sole distributor of mifepristone during the study period, to e...

Full description

Bibliographic Details
Main Author:	Rachel K. Jones
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Contraception: X
Subjects:	Abortion Abortion provision Medication abortion Mifepristone First trimester
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590151620300253

Similar Items

Different Time Schedules of Mifepristone and Misoprostol in Second Trimester Medical Abortion: A Comparative Study
by: Nalini Sharma, et al.
Published: (2017-07-01)

Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01)

Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
by: Anjali Gupta, et al.
Published: (2023-06-01)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
by: Ferid A. Abubeker, et al.
Published: (2020-07-01)

Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006-12-01)

Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006-12-01)

Abortion Services Utilization at KAHS during COVID-19 Lockdown
by: Rajiv Shah, et al.
Published: (2020-11-01)

Medical regimens for abortion at 12 weeks and above: a systematic review and meta-analysis
by: Katherine Whitehouse, et al.
Published: (2020-01-01)

Safety of mifepristone in medical abortion in hyperthyroidism pregnant mice
by: Yun-Hui Tang, et al.
Published: (2019-01-01)

Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series
by: Sruthi Chandrasekaran, et al.
Published: (2024-01-01)

Comment on “Is It Safe to Provide Abortion Pills Over The Counter? A Study on Outcome Following Self-Medication with Abortion Pills”
by: Laura J. Frye, et al.
Published: (2015-08-01)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
by: Tariku Shimels, et al.
Published: (2023-03-01)

Monitoring Medical Abortion Using Mifepristone/Misoprostol Combination with Ultrasonogram and Serum Human Chorionic Gonadotropin
by: Szu-Yuan Chou, et al.
Published: (2006-03-01)

Comparative study of sublingual versus vaginal misoprostol following mifepristone in early first trimester medical termination of pregnancy - a prospective study
by: B. L Pathak, et al.
Published: (2019-01-01)

Efficacy of Mifepristone/Misoprostol Combination for Medical Abortion Determined by Detection of Retained Products in a Community Hospital in Taipei, Taiwan
by: Szu-Yuan Chou, et al.
Published: (2004-06-01)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
by: Ellen R Wiebe, et al.
Published: (2020-01-01)

Low dose Mifepristone (100 mg) for medical termination of pregnancy
by: Shikha Seth, et al.
Published: (2011-09-01)

Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities
by: Amy Grossman, et al.
Published: (2023-04-01)

A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion
by: Nidhi Gupta, et al.
Published: (2023-01-01)

Medical abortion in India – An imperative need for task sharing
by: Nalini Arora, et al.
Published: (2022-01-01)

How did the introduction of mifepristone impact the availability of abortion care in Ottawa? A qualitative study with abortion patients
by: Kathryn J. LaRoche, et al.
Published: (2020-07-01)

Women’s perceptions of and experiences with the use of misoprostol for treatment of incomplete abortion in central Malawi: a mixed methods study
by: Bertha Magreta Chakhame, et al.
Published: (2023-02-01)

Self-managed medication abortion outcomes: results from a prospective pilot study
by: Heidi Moseson, et al.
Published: (2020-10-01)

Mifepristone Directly Disrupts Mouse Embryonic Development in Terms of Cellular Proliferation and Maturation In Vitro
by: Yu-Ting Su, et al.
Published: (2021-11-01)

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
by: Courtney Devane, et al.
Published: (2019-11-01)

Combined vesicouterine rupture during second-trimester medical abortion for fetal abnormality after prior cesarean delivery: A case report
by: Giuseppe Caruso, et al.
Published: (2021-10-01)

THE ABORTION PROBLEM SITUATION IN RUSSIA IN 2008-2015 YEARS
by: M. N. Bantyeva
Published: (2016-10-01)

Direct Effects of Mifepristone on Mice Embryogenesis: An In Vitro Evaluation by Single-Embryo RNA Sequencing Analysis
by: Yu-Ting Su, et al.
Published: (2023-03-01)

Primary abortion /
by: 344119 Jesudason, Christopher G.
Published: (1996)

A prospective study of sublingual misoprostol following mifepristone for second trimester termination of pregnancy
by: Ruchi Gupta, et al.
Published: (2019-07-01)

The role of birthplace and educational attainment on induced abortion inequalities
by: Yolanda González-Rábago, et al.
Published: (2017-01-01)

Comparison of the efficacy of sublingual, oral, and vaginal administration of misoprostol in the medical treatment of missed abortion during first trimester of pregnancy: A randomized clinical trial study
by: Behnaz Souizi, et al.
Published: (2020-01-01)

Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study
by: Yutaka Osuga, et al.
Published: (2023-01-01)

In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments
by: Ulrika Rehnström Loi, et al.
Published: (2023-01-01)

ALTERNATIVE APPROACHES TO MEDICAL ABORTION
by: K. Telbiyska, et al.
Published: (2024-03-01)

Social inequalities in utilization of a feminist telehealth abortion service in Brazil: A multilevel analysis
by: Sara Larrea, et al.
Published: (2022-12-01)

Abortion service delivery in clinics by state policy climate in 2017
by: Elizabeth Witwer, et al.
Published: (2020-01-01)

Comparison of the Effect of Letrozole and Misoprostol versus Misoprostol Alone on First Trimester Abortion
by: M Mokhtari, et al.
Published: (2023-03-01)

Comparison of cervical ripening with and without nitroglycerin before first trimester discharge abortion
by: Masoumeh Mirteimouri, et al.
Published: (2018-07-01)

A Case Report of a Patient with Spontaneously Resolving Unruptured Uterine Artery Pseudoaneurysm after Surgery for Miscarriage during the Early Stages of Pregnancy Using Manual Vacuum Aspiration
by: Toshiyuki Kakinuma, et al.
Published: (2022-01-01)